XML 30 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Oct. 31, 2017
Accounting Policies [Abstract]  
Schedule of Inventories

Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at October 31, 2017 and January 31, 2017:

 

    October 31, 2017     January 31, 2017  
Finished goods   $ 361,111     $ 443,623  

Schedule of Property and Equipment Estimated Useful Lives

Asset lives for financial statement reporting of depreciation are:

 

Machinery and equipment   2-7 years
Furniture and fixtures   3 years
Leasehold improvements   *

 

(*) Amortized on a straight-line basis over the term of the lease or the estimated useful lives, whichever period is shorter.

Schedule of Expenses of Slotting Fees, Sales Discounts and Allowances are Accounted as Direct Reduction of Revenues

Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows:

 

    Nine Months
Ended
October 31, 2017
    Nine Months
Ended
October 31, 2016
 
Gross Sales   $ 20,055,073     $ 12,976,986  
Less: Slotting, Discounts, Allowances     340,983       338,504  
Net Sales   $ 19,714,090     $ 12,638,482  

Schedule of Fair Value of Share-Based Payments

For the nine months ended October 31, 2017 and 2016, when computing fair value of share-based payments, the Company has considered the following variables:

 

    October 31, 2017     October 31, 2016  
Risk-free interest rate     1.18% to 1.60 %     1.25% to 1.33 %
Expected life of grants     2 to 3.51 years       2.5 to 3.5 years  
Expected volatility of underlying stock     139% to 298 %     172% to 179 %
Dividends     0 %     0 %

Schedule of Earnings Per Share, Basic and Diluted

The following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net income (loss) attributable to common stockholders per common share.

 

    For the Three Months Ended  
    October 31, 2017     October 31, 2016  
Numerator:            
Net income attributable to common stockholders   $ 203,354     $ 33,803  
Effect of dilutive securities:            
                 
Diluted net income   $ 203,354     $ 33,803  
                 
Denominator:                
Weighted average common shares outstanding - basic     31,503,665       27,257,834  
Dilutive securities (a):                
Series A Preferred     -       -  
Options     257,493       250,000  
Warrants     1,521,952       -  
                 
Weighted average common shares outstanding and assumed conversion - diluted     33,283,110       27,507,834  
                 
Basic net income per common share   $ 0.01     $ 0.00  
                 
Diluted net income per common share   $ 0.01     $ 0.00  
                 
(a) - Anti-dilutive securities excluded:     3,041,001       9,230,805  

 

    For the Nine Months Ended  
    October 31, 2017     October 31, 2016  
Numerator:            
Net income/(loss) attributable to common stockholders   $ 264,413     $ (580,435 )
Effect of dilutive securities:            
                 
Diluted net income (loss)   $ 264,413     $ (580,435 )
                 
Denominator:                
Weighted average common shares outstanding - basic     29,152,736       26,937,969  
Dilutive securities (a):                
Series A Preferred            
Options     257,493        
Warrants     1,521,952        
                 
Weighted average common shares outstanding and assumed conversion - diluted     30,932,182       26,937,969  
                 
Basic net income (loss) per common share   $ 0.01     $ (0.02 )
                 
Diluted net income (loss) per common share   $ 0.01     $ (0.02 )
                 
(a) - Anti-dilutive securities excluded:     3,041,001       9,230,805